ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2022 and some content may be unavailable. To unlock all content for 2022, please visit the archives.

Abstract: SA-PO395

A Predictive Model of the Time to ESKD Using Machine Learning

Session Information

Category: Dialysis

  • 701 Dialysis: Hemodialysis and Frequent Dialysis

Authors

  • Okita, Jun, Department of Endocrinology, Metabolism, Rheumatology and Nephrology, Faculty of Medicine, Oita University, Yufu, Oita, Japan
  • Nakata, Takeshi, Department of Endocrinology, Metabolism, Rheumatology and Nephrology, Faculty of Medicine, Oita University, Yufu, Oita, Japan
  • Noguchi, Emiko, Department of Endocrinology, Metabolism, Rheumatology and Nephrology, Faculty of Medicine, Oita University, Yufu, Oita, Japan
  • Koumatsu, Nobuchika, Department of Endocrinology, Metabolism, Rheumatology and Nephrology, Faculty of Medicine, Oita University, Yufu, Oita, Japan
  • Tasaki, Ayako, Department of Endocrinology, Metabolism, Rheumatology and Nephrology, Faculty of Medicine, Oita University, Yufu, Oita, Japan
  • Uchida, Hiroki, Department of Endocrinology, Metabolism, Rheumatology and Nephrology, Faculty of Medicine, Oita University, Yufu, Oita, Japan
  • Kudo, Akiko, Department of Endocrinology, Metabolism, Rheumatology and Nephrology, Faculty of Medicine, Oita University, Yufu, Oita, Japan
  • Fukuda, Akihiro, Department of Endocrinology, Metabolism, Rheumatology and Nephrology, Faculty of Medicine, Oita University, Yufu, Oita, Japan
  • Shimomura, Tsuyoshi, Hospital informatics center, Oita Medical University Hospital, Yuhu, Oita, Japan
  • Tanigawa, Masato, Department of Biophysics, Faculty of Medicine, Oita University, Yuhu, Oita, Japan
  • Shibata, Hirotaka, Department of Endocrinology, Metabolism, Rheumatology and Nephrology, Faculty of Medicine, Oita University, Yufu, Oita, Japan
Background

Predicting the risk of end-stage kidney disease (ESKD) and the time to renal replacement therapy (RRT) is useful not only for healthcare providers to treat CKD and prepare for renal replacement therapy (RRT) but also for patients to plan their life. Many studies have assessed the risk for ESKD using machine learning, but none have focused on the time to RRT. In this study, we investigated how to predict the time to RRT using machine learning.

Methods

This study was a retrospective cohort study. Patients who started RRT between April 2016 and March 2021 at Oita University Hospital were enrolled. A total of 13,323 data groups were extracted from the electronic medical records, including 34 laboratory data items (e.g., BUN and creatinine [Cr]) and 8 patient background items (e.g., age and gender) from the start of follow-up to the start of RRT. Items with missing values of more than 30% were excluded. The residual 9,838 data groups without missing values were trained by the machine; 80% of the data were randomly divided for training and 20% for testing, and supervised learning was performed with multiple algorithms (mainly nonlinear regression models, such as Random Forest and gradient-boosted decision trees) to create predictive models and evaluate the accuracy of the test data.

Results

In all, 147 patients (99 males) were enrolled with a mean age of 60.8 years. The most common ESRD etiology was diabetic nephropathy (44%). The mean Cr was 7.6 ± 2.0 mg/dL, and the estimated glomerular filtration rate (eGFR) was 6.1 ± 1.7 ml/min/1.73 m2 at induction. The optimal algorithm was the Random Forest regression, which created a predictive model that used six identical time variables (age, gender, height, weight, Cr, and eGFR). The model was highly accurate with a coefficient of determination (R2) of 0.96 and a mean absolute error of 159 days. The values predicted from the test data strongly correlated with the true values.

Conclusion

We predicted the time to start RRT with high accuracy using machine learning. Predicting the time to start RRT is useful for CKD treatment, and we plan to improve the accuracy of the model and consider its application to actual clinical practice in the future.